Categories: NewsPharmaceutical

Salimetrics CoreLab+ Expands Access to Dried Blood Spot Testing for Researchers

Salimetrics, a leading provider of biospecimen collection and salivary bioscience testing methods, is excited to announce the expansion of its dried blood spot (DBS) collection and laboratory testing services for academic and clinical researchers worldwide, now doubling the available capacity for DBS assay services while reducing lead times for specimen analysis by 50%.

CARLSBAD, Calif., June 10, 2025 /PRNewswire/ — Today, Salimetrics continues its mission to provide tools that support biobehavioral investigators across disciplines, from developmental science to behavioral health, to general health and wellness, and beyond. Backed by a leading expert in Dried Blood Spot Testing, Thom McDade, Ph.D., and rooted in the same core commitments that have shaped Salimetrics as a benchmark in salivary bioscience for Science, Support, Quality, Value, and Community, this expansion makes it easier than ever for researchers to integrate dried blood spot sampling into their study designs.

Dr. McDade has pioneered the use of dried blood spot (DBS) sampling as a minimally invasive, field-compatible alternative to venipuncture, enabling integrative, community-based investigations of human physiology and health. “The demand for DBS analyses has been growing. Now that Salimetrics has expanded the capacity for DBS testing, the research community will have open access to the highest-quality DBS assay services, and I am very happy to be part of that effort,” says Dr. McDade.

“Dried blood spot sampling enables measurement of a wide array of systemic biomarkers in peripheral blood,” says Douglas A. Granger, Ph.D., Chief Scientific and Strategy Advisor at Salimetrics. “Expanding access to dried blood spot testing builds scientific value by providing investigators the opportunity for multi-specimen type collections. Collecting both saliva and dried blood spots expands the nature of specific aims, increases significance and innovation, and increases the probability of high-impact observations. This expansion is the latest example of our commitment to provide a consistent, accessible, best-in-class shared resource to enable members of a broad research community to do their best science.”

To learn more about dried blood spot testing with Salimetrics, visit salimetrics.com/dried-blood-spots or request more information from Salimetrics’ support team, Dr. McDade, and Dr. Granger.

About Salimetrics Salimetrics is a trusted partner in providing accessible, reliable, reproducible and scientifically validated biospecimen methods for research studies. From saliva and dried blood spots collection methods to logistical support, to Salimetrics’ world-class Core Lab testing services, Salimetrics supports researchers at every stage of their study between grant submittal and publication. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC supports a wide spectrum of scientific specialties, including academic researchers, CROs, pharmaceuticals, and the immunodiagnostic industry around the world with their commitment to science, support, quality, value, and community.

View original content to download multimedia:https://www.prnewswire.com/news-releases/salimetrics-corelab-expands-access-to-dried-blood-spot-testing-for-researchers-302475644.html

SOURCE Salimetrics, LLC

Staff

Recent Posts

Restart Life Sciences Announces Closing First Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

38 minutes ago

TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

38 minutes ago

Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 5, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced…

38 minutes ago

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

6 hours ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

6 hours ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

6 hours ago